About Us

Unlocking the Researchers' Creativity
with Biotech Technologies Around the World

"Who cures a disease?" Usually, medical professionals, such as doctors, are mentioned in this question.
On the other hand, if asked who cures incurable diseases, we answer "Researchers."

It is estimated that only one out of 30,000 projects in drug discovery research succeeds in making a new medicine.
Notwithstanding, researchers never stop challenges through trial and error, With a passion for curing disease.

Trial and error takes place all over the world, and new ideas and experimental techniques are created on a daily basis.
However, these advancements exist in pieces, in different places respectively.

"Connecting the world's wisdom and technology will accelerate drug discovery."
This is the kind of world we are aiming for.
Like the ancient continent of Pangaea, where Europe, America, Asia, and Africa connected without borders, researchers from all over the world bring together the most advanced technologies to create new medicines.
To cure diseases which still incurable.
With this vision in mind, we are moving forward to connect Japan with the rest of the world.

Company Profile

Company Name
Pangaea, Inc.
Founded
September, 2018
Head Office
Nihonbashi Life Science Bldg.3, 3-8-3 Nihonbashi-Honcho, Chuo-ku, Tokyo 103-0023, Japan
Representative
Yuuki Yonekawa
Capital
¥20M
Business
Provide information on drug discovery research, biotech survey and transaction support
Clients
Chugai Pharmaceutical, Mitsubishi Tanabe Pharma, Yamaha Motor, etc.

Members

  • CEO  Yuuki Yonekawa

  • Yuuki Yonekawa

    CEO

    Yuuki has over 10 years of extensive experience in the life science and pharmaceutical R&D field to support cross-border business between Japanese and overseas companies.
    He founded Pangaea after working for a consulting firm and one of the major trading companies.
    At the trading company, Summit Pharmaceuticals International (SPI) in Sumitomo group, he was engaged in technology scouting of biotechs worldwide and business development of contract research and research alliance with Japanese pharmaceutical companies and university researchers.

  • Chief Strategy Officer Katsuya Shimizu

  • Katsuya Shimizu

    Chief Strategy Officer

    Katsuya has expert experience in working for major Nikkei IT companies and international IT companies.
    At the Japanese IT company, he was engaged in the development of SaaS product to support in-home medical care and community-based regional care system.
    And he worked to launch electronic medical records system at the international IT company.